Jupiter Bioscience acquires manu facility from Aurobindo Pharma

New Delhi, Aug 16 (UNI) Jupiter Bioscience Ltd today said it has acquired a manufacturing facility from Aurobindo Pharma Ltd, based in Andhra Pradesh.

The acquisition is part of its expansion programme for commercialisation of Speciality APIs, Chiral Intermediates and key Organic Intermediates and Bulk Peptide Raw Materials for the furtherance of the business of the company, a statement from Jupiter said here.

UNI RA VJ HS1940